Bulevirtide

Hepcludex 2 MG Polvo Para Solucion Inyectable

2,022 mg polvo para solución inyectableSpainMarketedAuthorised 26 Oct 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

HepcludexEuropean UnionAuthorised

HepcludexCanada · 2 MG / VIAL · Powder For Solution · Gilead Sciences Canada INCSame brand
HepcludexEuropean Union · Gilead Sciences Ireland UCSame brand
HepcludexCroatiaSame brand
HepcludexItaly · Polvere per soluzione iniettabile · Gilead Sciences Ireland UcSame brand
Hepcludex 2 mg poeder voor oplossing voor injectieNetherlands · Poeder voor oplossing voor injectie · Gilead Sciences Ireland UCSame brand
HepcludexUnited States · 8.5MG · injection · Gilead Sciences INC

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Bulevirtide

Hepcludex 2 MG Polvo Para Solucion Inyectable

2,022 mg polvo para solución inyectableSpainMarketedAuthorised 26 Oct 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

HepcludexEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Packs

Pack	Code	Status
HEPCLUDEX 2 MG POLVO PARA SOLUCION INYECTABLE, 30 viales	732023

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Bulevirtide
Strength: 2,022 mg
Dosage form: polvo para solución inyectable
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 26 Oct 2021
Registration: 1201446001
Marketing authorisation holder: Gilead Sciences Ireland Unlimited Company
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/20/1446